A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma. [electronic resource]
Producer: 20071030Description: 7960-5 p. digitalISSN:- 0008-5472
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cell Cycle -- drug effects
- Drug Evaluation, Preclinical
- Drug Synergism
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Furans -- administration & dosage
- Glioma -- drug therapy
- Humans
- PTEN Phosphohydrolase -- genetics
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinases -- drug effects
- Pyridines -- administration & dosage
- Pyrimidines -- administration & dosage
- Quinazolines -- administration & dosage
- TOR Serine-Threonine Kinases
- Treatment Outcome
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.